D'ADAMO, Maria Cristina
 Distribuzione geografica
Continente #
NA - Nord America 3.633
EU - Europa 2.501
AS - Asia 2.143
SA - Sud America 382
Continente sconosciuto - Info sul continente non disponibili 189
AF - Africa 62
OC - Oceania 2
Totale 8.912
Nazione #
US - Stati Uniti d'America 3.484
SG - Singapore 1.014
UA - Ucraina 473
IE - Irlanda 458
RU - Federazione Russa 312
CN - Cina 299
FR - Francia 286
BR - Brasile 281
HK - Hong Kong 270
IT - Italia 251
VN - Vietnam 191
SE - Svezia 190
DE - Germania 180
FI - Finlandia 122
KR - Corea 92
CA - Canada 69
GB - Regno Unito 69
IN - India 58
AR - Argentina 40
BD - Bangladesh 35
RO - Romania 34
TR - Turchia 33
IQ - Iraq 30
PL - Polonia 22
MX - Messico 20
NL - Olanda 20
ZA - Sudafrica 19
BE - Belgio 16
CH - Svizzera 16
JP - Giappone 16
EC - Ecuador 15
SA - Arabia Saudita 15
CO - Colombia 14
ID - Indonesia 13
AT - Austria 12
VE - Venezuela 12
CW - ???statistics.table.value.countryCode.CW??? 11
GT - Guatemala 9
PH - Filippine 9
PK - Pakistan 9
PR - Porto Rico 9
MA - Marocco 8
UZ - Uzbekistan 8
CR - Costa Rica 7
EG - Egitto 7
CL - Cile 6
CZ - Repubblica Ceca 6
ES - Italia 6
LT - Lituania 6
PY - Paraguay 6
AZ - Azerbaigian 5
GP - Guadalupe 5
JM - Giamaica 5
MY - Malesia 5
NI - Nicaragua 5
SC - Seychelles 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CI - Costa d'Avorio 4
EE - Estonia 4
GR - Grecia 4
HN - Honduras 4
IL - Israele 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
NP - Nepal 4
SV - El Salvador 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
DZ - Algeria 3
KG - Kirghizistan 3
LB - Libano 3
MT - Malta 3
NG - Nigeria 3
OM - Oman 3
RS - Serbia 3
BZ - Belize 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
ET - Etiopia 1
IR - Iran 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MR - Mauritania 1
NO - Norvegia 1
Totale 8.726
Città #
Singapore 665
Dublin 457
Chandler 424
Ashburn 346
Hong Kong 269
San Jose 261
Jacksonville 248
San Mateo 192
Santa Clara 129
Council Bluffs 125
Boardman 121
Moscow 109
Ann Arbor 97
Medford 95
Princeton 93
Seoul 88
Beijing 85
Dong Ket 83
Lauterbourg 83
Perugia 81
Wilmington 76
Munich 60
Andover 57
Los Angeles 47
Des Moines 42
Piscataway 40
New York 37
Altamura 35
Ho Chi Minh City 34
Saint Petersburg 33
Bucharest 32
São Paulo 29
Lawrence 28
Hanoi 27
The Dalles 24
Helsinki 20
Brooklyn 17
Dallas 17
Izmir 17
Orem 17
Brussels 16
Chennai 16
Johannesburg 15
Norwalk 15
Tokyo 15
Warsaw 15
Turku 14
Toronto 13
Rome 12
Baghdad 11
Falls Church 11
Houston 11
Willemstad 11
Woodbridge 11
Atlanta 10
Chicago 10
Frankfurt am Main 10
Montreal 10
Amsterdam 9
North Bergen 9
Da Nang 8
Denver 8
Guatemala City 8
Milan 8
San Paolo di Civitate 8
Shanghai 8
Auburn Hills 7
Den Haag 7
New Delhi 7
Rio de Janeiro 7
Stockholm 7
Buffalo 6
Dearborn 6
Erbil 6
Goiânia 6
London 6
Mumbai 6
Phoenix 6
Poplar 6
Redwood City 6
San José 6
Baku 5
Barnet 5
Belo Horizonte 5
Cairo 5
Columbus 5
Dhaka 5
Managua 5
Manchester 5
Medellín 5
Mexico City 5
Miami 5
Quito 5
Riyadh 5
Salvador 5
San Juan 5
Seattle 5
Vancouver 5
Abidjan 4
Buenos Aires 4
Totale 5.220
Nome #
Voltage-gated calcium channels modulate synaptic transmission at vestibular neurons. 146
Gain-of-function defects of astrocytic Kir4.1 channels in children with autism spectrum disorders and epilepsy 145
The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma 144
Adrenergic Stimulation of Tissue-type Plasminogen Activator Release in a Model of Vascular Perfusion in Rats. 139
Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies 139
A Calsequestrin-1 mutation associated with a skeletal muscle disease alters sarcoplasmic Ca2+ release 130
Modulation of hKv 1.1 and hKv 1.2 voltage gating and C-type inactivation by 5-HT2C receptors. 129
The Episodic Ataxia Type 1 Mutation F184C Alters the Zn2+ Modulation of the Human Kv1.4-Kv1.1/Kvbeta1 Channel 125
An Episodic Ataxia Type-1 (EA1) mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+ 124
Autism with Seizures and Intellectual Disability: Possible Causative Role of Gain-of-Function of the Inwardly-Rectifying K+ Channel Kir4.1. 124
Role of inwardly-rectifying potassium channels Kir5.1 in learning and memory processes in a mouse knock-out model. 123
Fotorecettori ed Epitelio Pigmentato della Retina; Meccanismi di Trasduzione e Rinnovamento. 121
Reconciling the discrepancies on the involvement of large-conductance Ca(2+)-activated K channels in glioblastoma cell migration 121
Abnormal Vascular Response to Fibrinolytic Stimulation inAged Rats. 120
Episodic Ataxias as Ion Channel Diseases. 119
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 118
The emerging role of the inwardly rectifying K+channels in autism spectrum disorders andepilepsy 114
Effects of Episodic Ataxia-Associated Mutations on hKv1.4-1.1/Kvbeta1 channels 113
ERG channels modulate the medial vestibular neurons processing of temporal information 113
A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia 111
Episodic Ataxia Type 1 Mutations Affect Fast Inactivation of K+ Channels by a Reduction in Either Subunit Surface Expression or Affinity for Inactivation Domain 110
Amiloride Inhibits Tissue-Type Plasminogen Activator (t-PA) Release from Vascular Endothelium 108
Commentary: A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia 108
A method to identify tissue cell subpopulations with distinct multi-molecular profiles from data on co-localization of two markers at a time: the case of sensory ganglia 107
5-HT2 receptors-mediated modulation of voltage-gated K+ channels and neurophysiopathological correlates 107
Antithrombotic Activity of Dermatan Sulphates, Heparin and their Combination in an Animal Model of Arterial Thrombosis. 105
Functional Properties of Voltage-Gated Potassium Channels Probed with Methanethiosulfonate Reagents. 105
Contributions of the central hydrophobic residue in the PXP motif of Voltage-Dependent K+ Channels to S6 flexibility and Gating Properties. 103
Episodic Ataxia Type 1 Mutation F184C Alters Zn2+-Induced Modulation of the Human Potassium Channel Kv1.4-Kv1.1/Kvbeta1.1 101
Changes in Primary Hemostasis During Thrombus Formation in a Model of Artherial Thrombosis in Rats. 101
Contributions of the central hydrophobic residue in the PXP motif of Voltage-Dependent K+ Channels to S6 flexibility and Gating Properties 101
K+ channelepsy: progress in the neurobiology of potassium channels and epilepsy 101
An activator of voltage-gated K + channels Kv1.1 as a therapeutic candidate for episodic ataxia type 1 100
Genetically-induced abnormalities of Kir2.1 channels: implications for short QT3 syndrome and autism/epilepsy phenotype. 99
Changes in Primary Hemostasis and Blood Coagulation During the Formation of an Arterial Thrombus in Rats. 98
Episodic ataxia type 1 mutations cause loss-of-function impairments of heteromeric channels formed by the Kv1.4 and Kv1.1 subunits. 98
Expression and function of a CP339,818-sensitive K+ current in a subpopulation of putative nociceptive neurons from adult mouse trigeminal ganglia 98
Update on the implication of potassium channels in autism: K(+) channelautism spectrum disorder 95
Identification of a New de Novo Mutation Underlying Regressive Episodic Ataxia Type I 95
The Episodic Ataxia Type 1 Mutation F184C Alters the Zn2+ Modulation of the Human Kv1.4-Kv1.1/Kvbeta1 Channel 94
Differential pH-sensitivity of Kir4.1 and Kir4.2 and Modulation by Heteropolymerisation with Kir5.1. 94
Episodic Ataxia Type 1 Mutations in the KCNA1 Gene Impair the Fast Inactivation Properties of the Human K+ Channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2. 94
Animal Models of Episodic Ataxia Type 1 (EA1). 94
Lethal digenic mutations in the K+channels kir4.1 (KCNJ10) and SLACK (KCNT1) associated with severe-disabling seizures and neurodevelopmental delay 94
Cathepsin G, a Polymorphonuclear Leucocyte Protease, Affects Endothelial Monolayer Integrity Both in Vivo and ex Vivo. 92
New insights into the pathogenesis and therapeutics of episodic ataxia type 1 91
Role of the S1 segment in the voltage-dependent gating of Kv1.1 channels revealed by naturally occurring pathogenic mutations. 90
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 89
Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature 89
Identification and functional characterization of a novel mutation in the KCNA1 gene of a Sicilian family affected by episodic ataxia type 1 86
Changes of the Hemostatic Balance in a Model of Aging in Rats. 86
Functional Characterization of an Episodic Ataxia Type-1 Mutation Occurring in the S1 Segment of hKv1.1 Channels. 86
Mutations in KCNA1 affect stoichiometry and fast inactivation of heteromeric K+ channels 85
Mutations in KCNA1 gene associated with episodic ataxia type-1 sindrome impair heteromeric voltage-gated K+ channel function. 85
A Novel KCNA1 Mutation Identified in an Italian Family Affected by Episodic Ataxia Type 1 85
Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene 85
Genetic investigation of children with ataxia using exome sequencing 84
De novo point mutations in patients diagnosed with ataxic cerebral palsy 84
Episodic Ataxia Type-1 Mutations in the hKv1.1 Cytoplasmic Pore Region Alter the Gating Properties of the Channel. 83
The neurobiology of episodic ataxia type 1: a Shaker-like K+ channel disorder. 82
Copertina della rivista The Journal of Physiology 82
Role of the vascular wall in the thrombotic Tendency of Hypercholesterolemic Rats. 81
Localization and Age Dependent Expression of the Inward Rectifier K+ Channel Kir 5.1 in a Mammalian Reproductive System. 81
Identification of a heteromeric interaction which influences the rectification, gating and pH-sensitivity of Kir4.1/Kir5.1 potassium channels. 81
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 80
Differential pH-sensitivity of Kir4.1 and Kir4.2 and modulation by heteropolymerisation with Kir5.1 79
Gating properties of human heteromeric voltage-gated potassium channels and effects of episodic ataxia type-1 mutations. 79
Kcnj16 (Kir5.1) Gene Ablation Causes Subfertility and Increases the Prevalence of Morphologically Abnormal Spermatozoa 78
The Response of Vascular Fibrinolysis to the Adrenergic Stimulation is Abnormal in Aged Rats. 78
Enhanced Vascular Plasminogen Activator (t-PA) Release by Epinephrine in Aged Rats 78
Different Response of Vascular Fibrinolysis to Adrenergic Stimulation in Young and Aged Rats 78
Copertina della rivista scientifica: Neuroscience 77
Genetic inactivation of Kcnj16 identifies Kir5.1 as an important determinant of neuronal PCO2/pH sensitivity 77
pH-Dependence of the Inwardly Rectifying Potassium Channel Kir5.1 and Localisation in Renal Tubular Epithelia 76
ERG channels regulate the excitability of medial vestibular neurons 75
Copertina della rivista FEBS Letters 75
Mutations in the KCNA1 Gene Associated with Episodic Ataxia Type-1 Syndrome Impair Heteromeric Voltage-Gated K+ Channel Function 74
The Kir5.1 Potassium Channel is an Important Determinant of Neuronal PCO2/pH Sensitivity 74
Role of RPTPα and Tyrosine Phosphorylation in the Serotonergic Inhibition of Voltage-Dependent Potassium Channels. 73
Modulation of delayed rectifier K+ channels by 5HT2c receptors. 73
The Role of alfa-adrenergic Receptors in the Acute Release of Tissue-Type Plasminogen Activator (t-PA) in a Model of Vascular Perfusion in Rats. 72
Gain-of-Function of the Inwardly-Rectifying K+ Channel Kir4.1 Contributes to Autism with Seizures and Intellectual Disability. 72
Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation. 70
The Adrenergic Mechanism of Acute t-PA Release in Normal and Diseased Animals 69
Effect of Aspirin on the Fibrinolytic Response in Perfused Rat Hindquarters 69
Episodic Ataxia Type 1 69
Effects of dyslipidemia on t-PA release in rats. 68
Expression in e.coli and purification of recombinant fragments of wild type and mutant human prion protein 68
Vascular Fibrinolysis in Aging: Enhanced Response to Adrenergic Stimulation. 68
Morphological and Homeostatic Changes in Rats with Abdominal Arterial Prosthesis. 66
Hypercoagulable State in Aged Rats. 64
Prostacyclin is Required for t-PA Release After Venous Occlusion 63
Neutrophil Derived Cathepsin G Induce Potentially Thrombogenic Changes in Human Endothelial Cells: a scanning electron microscopy study in static and dynamic conditions. 63
Episodic ataxia type-1 mutations in the hKv1.1 citoplasmic pore region alter the gating properties of the channels. 63
KCNA4 deficiency leads to a syndrome of abnormal striatum, congenital cataract and intellectual disability 59
Murine Models of EA1 50
Totale 8.912
Categoria #
all - tutte 40.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022553 0 0 0 0 13 3 12 248 7 26 95 149
2022/20231.360 99 121 35 99 129 159 1 65 594 2 44 12
2023/2024444 37 50 23 5 12 1 96 1 56 20 91 52
2024/20251.207 10 121 44 59 178 61 36 93 232 58 220 95
2025/20262.545 196 189 127 351 335 216 420 121 258 233 55 44
2026/2027826 37 89 122 503 75 0 0 0 0 0 0 0
Totale 8.912